Yeah, sometimes you just need to shut down for a while.
there were times i had to tell my daughter i can't talk anymore. thinking using thought processes, takes sooooo much energy.
How's it going on your end? You hanging in there? This drudgery sure gets old. Hear on the news you guys are having some heavy weather. Here it is unseasonably cold but sunny.
When is your stop date? You are at or near the 3/4 mark aren't you? How's your bloodwork looking? Im doing ok, enzymes in the 20's but white and red counts dangerously low at this point. I knocked the Riba down a notch, hope that helps. Thinking about reducing IFN and slowly tapering it off, what do you think? Im scared to, but Im thinking at this point it might be a good plan.
With the little functioning brain cells I have left, I can't seem to make a decision on it. Thinking to reduce it by half. Im down to 1000 riba a day but might lower it to 800 to see if it will help. Im about at the end of my rope with this utter lack of energy most of the time.My hubby keeps saying that the "grumpy factor" is gettin' old. LOL
take care, I thought about you while watching the Masters
25 down, 21 to go. In the dog days but muddling through. With Aranesp, hgb stays beteeen 11 and 12, which is what the plan was. Insurance will pay when below 12 and I did not want to be a depths of anemia warrior. No neup yet, which is good. Full intention to do the 46 but if disaster strikes (insurance problems etc) feel that I must make it to at least 38. Expect it all will work this time, will not do this again. Need to get in for 24 week stuff (pcr,lft,tsh), just kinda lazy. Since und since 2 and will not let doc tell me ast/alt it's almost academic. But am religious with the cbc's. Hope the left coast is fine, very nice weather on the right.
Haven't missed work due to tx. My co. has a liberal vacation allotment, so I've taken time over the holidays, string a few long weekends and so on. But pace is something I've really worked at this tx. Not only physical energy conservation with good diet and some exercise but thinker capacity too.
left coast. its a blustery day. i am getting rather accustomed to what might be the impending changes of "global warming"
i didn't realize you have to treat for so many weeks. are you working through this? i guess the alternative is disabiltiy...
it was very disabling to me. i thought i had a stronger constitution and could at least work a reduced workload. nada...
hope you can continue to endure the tx.
rose
....my doc calls it "the nastiest" ....Actually, kind words for ribavirin.
I was looking for info to post to Lilla about Ribivirin and I came across this article, and I thought I'd share it. Lilla, riba is a nasty drug, my doc calls it "the nastiest" but, for many it works to eradicate the virus. Many cancers are caused by viruses. There is a risk of cancer with having Hep C or with treating it it seems. Here's a bit of good news regarding some cancers and specifically liver cancer.
http://www.sciencedaily.com/upi/index.php?feed=Science&article=UPI-1-20070214-10223500-bc-us-livercancer.xml
"Liver cancer is good gene therapy target
SAN DIEGO, Feb. 14 (UPI) -- U.S. cancer researchers say they've determined liver cancer cells are excellent targets for gene therapy using adenoviral vectors.
The University of California-San Diego scientists say their findings signal a new way to treat metastatic cancers of the breast and colon that have spread to the liver.
The research team, led by Dr. Tony Reid of the university's Moores Cancer Center, says the study also demonstrates that in cancerous cells the receptor for adenovirus, called the coxsackie-adenoviral receptor, is expressed randomly over the surface of the cell and is exposed to the blood vessels.
"Since the receptor is distributed randomly on the surface of tumor cells, the doorway is open for the adenoviral vectors circulating in the blood stream to infect and kill these cells," said Reid. "At the same time, normal liver cells are protected. These findings may signal a new way to treat any cancer that has spread to the liver."
The study is detailed in the current issue of the journal Nature Cancer Gene Therapy.